Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Inserm patents


Recent patent applications related to Inserm. Inserm is listed as an Agent/Assignee. Note: Inserm may have other listings under different names/spellings. We're not affiliated with Inserm, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "I" | Inserm-related inventors


Insonification method for obtaining a predetermined field of ultrasonic waves and production method for making an ultrasonic lens for these purposes

In order to obtain a predetermined ultrasonic wave field in a homogeneous internal part of a medium masked by an aberrating barrier, an ultrasonic lens is interposed between the emitting ultrasonic probe and the aberrating barrier. The ultrasonic lens is calculated by using a model of the medium comprising a mapping of ultrasonic wave propagation properties obtained from actual imaging of the medium such that when the ultrasound probe sends a predetermined ultrasonic wave, said predetermined wave generates the predetermined objective ultrasonic wave field in the medium.. ... Inserm

Method and apparatus for generating focused ultrasonic waves with surface modulation

The invention relates to a method for generating ultrasonic waves focused on a focal zone (5) in order to carry out biological lesions, comprising the activation of a plurality of ultrasonic transducer elements (3). According to the invention: a target zone, in which homogenization of the supply of energy of the ultrasonic waves emitted by the ultrasonic transducer elements is desired, is chosen, the focusing effect and the acoustic attenuations of the ultrasonic waves on their path between the target zone and the ultrasonic transducer elements (3) are determined, the focusing effect and the acoustic attenuations of the ultrasonic waves are compensated, with ultrasonic transducer elements (3) at least some of which have non-identical emission surfaces such that in the target zone, the supply of energy of the ultrasonic waves emitted by the different ultrasonic transducer elements (3) is more or less identical.. ... Inserm

Fkbp52-tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction

The invention relates generally to neuroprotection and repair in neurological disorders involving tau dysfunction (including alzheimer's disease). The invention describes and includes a direct interaction between proteins fkbp52 and tau. ... Inserm

Btla antibodies and uses thereof

The invention relates to btla antibodies that block btla-hvem interaction and uses thereof.. . ... Inserm

Pixel cell circuit and implant

A pixel cell circuit comprises an electrode, one or more main photosensitive elements electrically coupled to the electrode for outputting a stimulation signal to the electrode responsive to light illumination, and a shunt arrangement comprising a shunt switch electrically coupled in parallel across the one or more photosensitive elements, and a control arrangement operatively coupled to the shunt switch and configured for placing the shunt switch in an open state responsive to incident light received at the pixel cell and placing the shunt switch in a closed state if no incident light is received at the pixel cell.. . ... Inserm

Method for the 3d reconstruction of a scene

The present invention concerns a method for the 3d reconstruction of a scene comprising the matching (610) of a first event from among the first asynchronous successive events of a first sensor with a second event from among the second asynchronous successive events of a second sensor depending on a minimisation (609) of a cost function (e). The cost function comprises at least one component from: —a luminance component (ei) that depends at least on a first luminance signal (iu) convoluted with a convolution core (gσ(t)), the luminance of said pixel depending on a difference between maximums (te−,u,te+,u) of said first signal; and a second luminance signal (iv) convoluted with said convolution core, the luminance of said pixel depending on a difference between maximums (te−,v,te+,v) of said second signal; —a movement component (em) depending on at least time values relative to the occurrence of events located at a distance from a pixel of the first sensor and time values relative to the occurrence of events located at a distance from a pixel of the second sensor.. ... Inserm

Method for processing an asynchronous signal

Disclosed is a method for processing an asynchronous signal produced by a light sensor, the sensor having a pixel matrix disposed opposite a scene, the method including: receiving from the light sensor the asynchronous signal including, for each pixel of the matrix, successive events from the pixel; analysing the asynchronous signal using activity profiles as events are received in the asynchronous signal. The activity profile includes at least, for each pixel of the sensor, an activity value that decreases as a function of the time that has passed since the most recent event among the successive events from the pixel.. ... Inserm

Anaplerotic therapy of huntington disease and other polyglutamine diseases

The present invention relates to a method for treating and/or preventing huntington disease and other polyglutamine disease, comprising the step of administering an effective amount of a precursor of propionyl-coa to an individual in need thereof.. . ... Inserm

Laser printing method and device for implementing said method

A method for printing uses at least one ink. The method includes: a step of focusing a laser beam so as to generate a cavity in an ink film; a step of forming at least one ink droplet from a free surface of the ink film; and a step of depositing the droplet onto a depositing surface of a receiving substrate positioned at a given distance from the film. ... Inserm

Method and device for enhancing memory consolidation

The present invention relates to methods and devices to consolidate memory and/or cognitive functions by monitoring brain rhythms and delivering a stimulus at an appropriate stage of sleep cycle.. . ... Inserm

Method for preparing a vaccine antigen, resulting vaccine antigen and uses

The present invention relates to a method for preparing a vaccine antigen, which includes a step of fragmenting a biological membrane associated with said vaccine antigen by treating said biological membrane with at least one calixarene of formula (ii): wherein: x is a —(ch2)-co2y group and y is an alkaline metal or one of the pharmaceutically acceptable salts thereof, wherein said resulting vaccine antigen also includes a fragment of the biological membrane associated with said antigen. The present invention also relates to a vaccine that can be produced by implementing the method, including a calixarene of formula (ii) in carrier format, with a quantity of 0.1 to 1,000 μg in the total weight of the vaccine. ... Inserm

Transgenic rpe cells overexpressing otx2 for the treatment of retinal degeneration

The present invention relates to methods and composition for use in the treatment of retinal degeneration, in particular retinal degeneration due to retinal pigment epithelium dysfunction.. . ... Inserm

Selective nox-1 inhibitor peptides and uses thereof

The present invention relates to novel peptides, compositions and methods for the prevention and/or treatment of pathological conditions and diseases associated with nadph oxidase 1 (nox1) activity, and/or increased reactive oxygen species (ros) production. The novel peptides are thus particularly useful for treating and/or preventing cancer, atherosclerosis, angiogenesis, and aging.. ... Inserm

Method for laser printing biological components, and device for implementing said method

A method for printing uses at least one bio-ink. The method also uses at least one laser print head to deposit at least one droplet of at least one bio-ink onto a depositing surface of a receiving substrate. ... Inserm

09/28/17 / #20170276775

Acoustic imaging method and device

According to the invention, n incident acoustic waves ei(t), obtained by linearly combining n elemental incident waves e0i(t) with an encoding matrix hc are consecutively transmitted in a medium to be imaged. N reverberated waves ri(t) from the medium to be imaged are then consecutively detected, following the transmission of the n incident waves; then n elemental reverberated waves r0i(t) are determined by linearly combining the detected n reverberated waves ri(t) with a decoding matrix hd. ... Inserm

09/14/17 / #20170260588

Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors

The invention relates to methods for detecting inactivation of the dna homologous recombination pathway in a patient, and in particular for detecting brca1 inactivation.. . ... Inserm

09/14/17 / #20170258871

Combined use of a trka inhibitor and an epha2 inhibitor for using in the treatment of solid cancers, and method for the prognosis of survival of a patient who has a solid cancer

The invention relates to an epha2 inhibitor for the use thereof in the treatment of solid cancer treated with a trka inhibitor, and a trka inhibitor for the use thereof in the treatment of solid cancer treated with an epba2 inhibitor. The invention also relates to a method for the prognosis of survival of a patient who has a solid cancer, comprising a step of detecting the expression of trka and epha2 in a biological sample of the patient, the co-expression of trka and epha2 being associated with a poor prognosis of survival of the patient.. ... Inserm

08/24/17 / #20170242015

Map3k8 as a marker for selecting a patient affected with an ovarian cancer for a treatment with a mek inhibitor

The present invention relates to the use of map3k8 protein to predict clinical outcome of a patient affected with a cancer, in particular ovarian cancer, or to select a patient for a treatment comprising one mek inhibitor. The invention further relates to a method for monitoring a patient affected with a high-map3k8 ovarian cancer (i.e. ... Inserm

08/03/17 / #20170218082

Human soluble cd146, preparation and uses thereof

The present invention relates to compositions and methods for modulating angiogenesis in vivo, ex vivo or in vitro. More particularly, the invention relates to a soluble cd146 protein usable in the context of human therapy, as well as to corresponding antibodies. ... Inserm

08/03/17 / #20170216448

Inhibitors of fusion between viral and cell membranes as well as compositions and methods of using them

The present application relates to an inhibitor of fusion between a viral membrane from an enveloped virus and a cell membrane, where the viral membrane comprises a fusion mediating protein including a c-terminal peptide. The inhibitor comprises the c-terminal peptide of the fusion mediating protein from an enveloped virus and tocopherol or a derivative or pharmaceutically acceptable salt thereof attached to the c-terminal peptide. ... Inserm

07/27/17 / #20170211043

Method for in vitro production of adipocyte progenitors and adipocytes

The present invention relates to a method for in vitro production of adipocyte progenitors and adipocytes from pluripotent stem cells, in particular from induced pluripotent stem cells, as well as to the use of the adipocyte progenitors and adipocytes thus obtained for therapeutic or screening purposes.. . ... Inserm

07/27/17 / #20170210710

2-oxo-3,4-dihydropyridine-5-carboxylates and their use

The present invention is directed to novel compounds of formula (i), pharmaceutically acceptable salts or solvates thereof, and their use.. . ... Inserm

07/06/17 / #20170191084

Method for producing methane by means of aerobic co-culture of anaerobic micro-organisms

The present invention relates to the biological production of methane (biogas) by co-culture in an aerobic atmosphere of a methanogenic bacterium and of an anaerobic bacterium capable of producing hydrogen, in a culture medium comprising or being supplemented with carbohydrate compound(s), notably starch and/or sugars, and supplemented with antioxidant compound(s).. . ... Inserm

07/06/17 / #20170190687

Imidazol- or 1,2,4-triazol-derivatives and their use

The present invention is directed to novel compounds of formula (i), pharmaceutically acceptable salts or solvates thereof, and their use.. . ... Inserm

06/29/17 / #20170183620

Use of uric acid for culturing bacteria sensitive to oxygen tension

The present invention relates to a method for cultivating in vitro in an acellular culture medium, bacteria for which the growth is sensitive to oxygen content, said bacterium being selected from anaerobic bacteria and intracellular micro-aerophilic bacteria, characterized in that uric acid is added into said acellular culture medium, and said bacterium is cultivated in said culture medium in the presence of oxygen.. . ... Inserm

06/01/17 / #20170151235

Sulphate salts of n-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1h-benzo[d]imidazol-2-amine, preparation thereof and use of the same

The present invention relates to sulphate salts of n-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1h-benzo[d]imidazol-2-amine and pharmaceutically acceptable solvates thereof, preparation thereof, pharmaceutical compositions containing them and use of the same in the treatment and/or prevention of neurodegenerative diseases.. . ... Inserm

04/13/17 / #20170100378

Methods and pharmaceutical compositions for the treatment of myelodysplastic syndromes

The present invention provides methods and pharmaceutical compositions designed to intervene in this defective process and to promote or restore erythrocyte maturation in individuals suffering from a myelodysplastic syndrome. The methods involve maintaining the activity of gata-1 by preventing sequestration of hsp70 in the cytoplasm. ... Inserm

03/16/17 / #20170072032

Prenatal therapy to induce immune tolerance

Constructs and methods for inducing immune tolerance during gestation, e.g. In utero, are provided. ... Inserm

03/02/17 / #20170056397

Selective histamine h4 receptor antagonists for the treatment of vestibular disorders

The invention relates to histamine h4 receptor antagonists or inhibitors of histamine h4 receptor gene expression for the treatment and/or the prevention of vestibular disorders.. . ... Inserm

02/23/17 / #20170052202

Methods for diagnosing and treating iron dysregulation

The present invention relates to methods for diagnosing and treating iron overload and iron deficiency.. . ... Inserm

02/16/17 / #20170044234

Polypeptides and uses thereof for reducing cd95-mediated cell motility

The present invention relates to polypeptides and uses thereof for reducing cd95-meditated cell motility. In particular, the present invention relates to a polypeptide having an amino acid sequence having at least 70% of identity with the amino acid sequence ranging from the amino-acid residue at position 175 to the amino-acid residue at position 191 in seq id no:1.. ... Inserm

01/19/17 / #20170014426

Ulipristal acetate for prevention and treatment of breast tumors

. . The invention relates to the use of ulipristal acetate, or any of its metabolites, in preventing or treating a breast tumor in a patient, preferably a patient that carries a mutation in brca1 gene.. . ... Inserm








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Inserm in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Inserm with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###